CASM : Summary for CAS Medical Systems, Inc. - Yahoo Finance

U.S. Markets open in 9 hrs 7 mins

CAS Medical Systems, Inc. (CASM)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.54+0.06 (+4.05%)
At close: 4:00PM EST
People also watch
CRDCAHPIBVXCEMIATEC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.48
Open1.47
Bid1.05 x 200
Ask2.14 x 100
Day's Range1.46 - 1.54
52 Week Range1.38 - 2.15
Volume6,141
Avg. Volume57,445
Market Cap41.19M
Beta-1.12
PE Ratio (TTM)-8.51
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Researchlast month

    CASM: Q4 Revenue Growth of 14%, Further Acceleration in 2H 2017

    CAS Medical (CASM) preannounced Q4 and full year 2016 revenue and provided general guidance for 2017.  While the Q4 numbers were slightly below what we had been looking for, the revision implies FY2016 revenue growth will still be a relatively beefy 14% and driven by 17% growth of the company’s flagship FORE-SIGHT tissue oximetry segment.  The revision also has no impact on our forecasted EPS or calculated per-share price target. Much of the difference relative to our prior revenue estimate relates to a greater number of monitor returns in Q4 (37 A vs. 21 E) – but despite this, CASM was still able to ship a record number of monitors to U.S. customers.  We remind investors that a certain number of monitors are regularly returned each quarter as lower utilization sites are weeded out – Q4 was somewhat of an anomaly due to the loss of a top-50 account which resulted in greater than usual returns and what we expect to be a short-term hiccup in net monitor placement growth.  While as of the Q3 call (mid-November) management was still guiding to hit their goal of 400 monitor placements in 2016, the Q4 preannouncement implies total placements will come in about 5% shy of this, or 380.

  • GlobeNewswire2 months ago

    CASMED Reports Preliminary Net Sales for the 2016 Fourth Quarter and Full Year

    BRANFORD, Conn., Jan. 10, 2017-- CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the three and 12 months ended ...

  • How Cogentix Medical Inc (CGNT) Ranks Amongst Its Peers
    Insider Monkey2 months ago

    How Cogentix Medical Inc (CGNT) Ranks Amongst Its Peers

    The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of course, most hedge funds and other asset managers have been underperforming main stock market indices since the middle of 2015. Interestingly though, smaller-cap stocks registered their best performance relative to the large-capitalization […]